SIMILAR PATTERNS OF AMINO ACIDS FOR 1XOQ_B_ROFB501_0
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1d5t | GUANINE NUCLEOTIDEDISSOCIATIONINHIBITOR (Bos taurus) |
PF00996(GDI) | 5 | LEU A 231TYR A 404THR A 15ILE A 18PHE A 410 | None | 1.41A | 1xoqB-1d5tA:undetectable | 1xoqB-1d5tA:22.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ehk | BA3-TYPECYTOCHROME-C OXIDASE (Thermusthermophilus) |
PF00115(COX1) | 5 | LEU A 83TRP A 239ILE A 78SER A 150PHE A 152 | None | 1.33A | 1xoqB-1ehkA:undetectable | 1xoqB-1ehkA:19.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1fiu | TYPE II RESTRICTIONENZYME NGOMI (Neisseriagonorrhoeae) |
PF09015(NgoMIV_restric) | 5 | HIS A 13ASP A 276LEU A 246ILE A 47SER A 40 | None | 1.44A | 1xoqB-1fiuA:undetectable | 1xoqB-1fiuA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1fw8 | PHOSPHOGLYCERATEKINASE (Saccharomycescerevisiae) |
PF00162(PGK) | 5 | LEU A 127PRO A 130THR A 294ILE A 296PHE A 134 | None | 1.49A | 1xoqB-1fw8A:undetectable | 1xoqB-1fw8A:21.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1g1a | DTDP-D-GLUCOSE4,6-DEHYDRATASE (Salmonellaenterica) |
PF16363(GDP_Man_Dehyd) | 5 | LEU A 207PRO A 209TYR A 334THR A 330ILE A 327 | None | 1.29A | 1xoqB-1g1aA:undetectable | 1xoqB-1g1aA:22.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1je6 | MHC CLASS ICHAIN-RELATEDPROTEIN (Homo sapiens) |
PF00129(MHC_I)PF07654(C1-set) | 5 | HIS A 156ASP A 72LEU A 73THR A 143PHE A 110 | None | 1.30A | 1xoqB-1je6A:undetectable | 1xoqB-1je6A:21.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1kgp | RIBONUCLEOTIDEREDUCTASE PROTEINR2F (Corynebacteriumammoniagenes) |
PF00268(Ribonuc_red_sm) | 5 | ASP A 51LEU A 188PRO A 179ILE A 194PHE A 70 | None | 1.48A | 1xoqB-1kgpA:undetectable | 1xoqB-1kgpA:23.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1mio | NITROGENASEMOLYBDENUM IRONPROTEIN (BETA CHAIN) (Clostridiumpasteurianum) |
PF00148(Oxidored_nitro) | 5 | TYR B 118LEU B 111ILE B 84SER B 70PHE B 71 | None | 1.41A | 1xoqB-1mioB:undetectable | 1xoqB-1mioB:22.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1soj | CGMP-INHIBITED3',5'-CYCLICPHOSPHODIESTERASE B (Homo sapiens) |
PF00233(PDEase_I) | 5 | HIS A 737ASP A 937PRO A 941SER A 990PHE A 991 | IBM A2111 ( 4.8A) MG A2123 (-2.5A)NoneNoneIBM A2111 (-3.6A) | 1.25A | 1xoqB-1sojA:42.2 | 1xoqB-1sojA:31.99 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1soj | CGMP-INHIBITED3',5'-CYCLICPHOSPHODIESTERASE B (Homo sapiens) |
PF00233(PDEase_I) | 8 | TYR A 736HIS A 737ASP A 937PRO A 941TRP A 951THR A 952ILE A 955PHE A 991 | IBM A2111 (-4.5A)IBM A2111 ( 4.8A) MG A2123 (-2.5A)NoneNoneIBM A2111 ( 4.8A)IBM A2111 (-4.2A)IBM A2111 (-3.6A) | 0.52A | 1xoqB-1sojA:42.2 | 1xoqB-1sojA:31.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1uf2 | CORE PROTEIN P3 (Rice dwarfvirus) |
PF09231(RDV-p3) | 5 | LEU A 642THR A 559ILE A 562SER A 589PHE A 591 | None | 1.36A | 1xoqB-1uf2A:undetectable | 1xoqB-1uf2A:16.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1um1 | KIAA1849 PROTEIN (Homo sapiens) |
PF00595(PDZ) | 5 | ASP A 27LEU A 38THR A 99ILE A 103SER A 56 | None | 1.48A | 1xoqB-1um1A:undetectable | 1xoqB-1um1A:15.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1urt | CARBONIC ANHYDRASE V (Mus musculus) |
PF00194(Carb_anhydrase) | 5 | LEU A 256PRO A 195TRP A 209THR A 208ILE A 210 | None | 1.43A | 1xoqB-1urtA:undetectable | 1xoqB-1urtA:21.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1viw | ALPHA-AMYLASE-INHIBITOR (Phaseolusvulgaris) |
PF00139(Lectin_legB) | 5 | ASP B 83LEU B 82ILE B 137SER B 199PHE B 66 | NoneNoneNoneNAG B 509 (-2.4A)None | 1.46A | 1xoqB-1viwB:undetectable | 1xoqB-1viwB:19.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1w3i | 2-KETO-3-DEOXYGLUCONATE ALDOLASE (Sulfolobussolfataricus) |
PF00701(DHDPS) | 5 | TYR A 246LEU A 23TYR A 255THR A 249SER A 200 | None | 1.42A | 1xoqB-1w3iA:undetectable | 1xoqB-1w3iA:22.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1z45 | GAL10 BIFUNCTIONALPROTEIN (Saccharomycescerevisiae) |
PF01263(Aldose_epim)PF16363(GDP_Man_Dehyd) | 5 | ASP A 490LEU A 488TYR A 520THR A 535ILE A 427 | None | 1.29A | 1xoqB-1z45A:undetectable | 1xoqB-1z45A:18.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1zkl | HIGH-AFFINITYCAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 7A (Homo sapiens) |
PF00233(PDEase_I) | 6 | TYR A 211HIS A 212ASP A 362PRO A 366TRP A 376PHE A 416 | IBM A 503 (-4.6A)None ZN A 501 (-2.5A)NoneNoneIBM A 503 (-3.4A) | 0.36A | 1xoqB-1zklA:45.5 | 1xoqB-1zklA:33.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1znp | HYPOTHETICAL PROTEINATU3615 (Agrobacteriumfabrum) |
PF06172(Cupin_5) | 5 | TYR A 25HIS A 19THR A 28ILE A 43SER A 40 | None | 1.35A | 1xoqB-1znpA:undetectable | 1xoqB-1znpA:16.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2amx | ADENOSINE DEAMINASE (Plasmodiumyoelii) |
PF00962(A_deaminase) | 5 | HIS A 239ASP A 324LEU A 60ILE A 183SER A 147 | CO A1000 (-3.4A)NoneNoneNoneNone | 1.26A | 1xoqB-2amxA:undetectable | 1xoqB-2amxA:25.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2evr | COG0791: CELLWALL-ASSOCIATEDHYDROLASES(INVASION-ASSOCIATEDPROTEINS) (Nostocpunctiforme) |
PF00877(NLPC_P60) | 5 | ASP A 164THR A 104ILE A 101SER A 136PHE A 134 | None | 1.38A | 1xoqB-2evrA:undetectable | 1xoqB-2evrA:23.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2h18 | ADP-RIBOSYLATIONFACTOR-LIKE PROTEIN8A (Homo sapiens) |
PF00025(Arf) | 5 | LEU A 128THR A 24ILE A 67MET A 21SER A 90 | None | 1.25A | 1xoqB-2h18A:undetectable | 1xoqB-2h18A:24.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2hbw | NLP/P60 PROTEIN (Trichormusvariabilis) |
PF00877(NLPC_P60) | 5 | ASP A 164THR A 104ILE A 101SER A 136PHE A 134 | None | 1.36A | 1xoqB-2hbwA:undetectable | 1xoqB-2hbwA:21.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2jem | ENDO-BETA-1,4-GLUCANASE (Bacilluslicheniformis) |
PF01670(Glyco_hydro_12) | 5 | LEU A 160TYR A 89ILE A 251MET A 73PHE A 240 | None | 1.11A | 1xoqB-2jemA:undetectable | 1xoqB-2jemA:19.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2oze | ORF DELTA' (Streptococcuspyogenes) |
PF13614(AAA_31) | 5 | ASP A 156LEU A 66ILE A 159MET A 181PHE A 283 | None | 1.41A | 1xoqB-2ozeA:undetectable | 1xoqB-2ozeA:23.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2qyk | CYCLIC AMP-SPECIFICPHOSPHODIESTERASEHSPDE4A10 (Homo sapiens) |
PF00233(PDEase_I) | 12 | TYR A 371HIS A 372ASP A 530LEU A 531PRO A 534TYR A 541TRP A 544THR A 545ILE A 548MET A 569SER A 580PHE A 584 | NPV A 3 (-4.4A)NPV A 3 (-4.6A) ZN A 1 (-2.5A)NoneNoneNoneNoneNPV A 3 ( 4.7A)NPV A 3 (-3.8A)NPV A 3 (-3.1A)NPV A 3 (-4.5A)NPV A 3 (-3.3A) | 0.49A | 1xoqB-2qykA:51.9 | 1xoqB-2qykA:82.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2qym | PHOSPHODIESTERASE 4C (Homo sapiens) |
PF00233(PDEase_I) | 10 | TYR A 281HIS A 282ASP A 440LEU A 441PRO A 444TYR A 451TRP A 454THR A 455ILE A 458PHE A 494 | NoneNone ZN A 1 (-2.5A)NoneNoneNoneNoneNoneNoneNone | 0.60A | 1xoqB-2qymA:43.4 | 1xoqB-2qymA:82.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2r8q | CLASS IPHOSPHODIESTERASEPDEB1 (Leishmaniamajor) |
PF00233(PDEase_I) | 5 | TYR A 680HIS A 681ASP A 835TRP A 849PHE A 890 | IBM A 3 ( 4.7A)IBM A 3 ( 4.8A) ZN A 1 (-2.6A)NoneIBM A 3 (-3.6A) | 0.42A | 1xoqB-2r8qA:39.4 | 1xoqB-2r8qA:30.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3b2r | CGMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE (Homo sapiens) |
PF00233(PDEase_I) | 5 | TYR A 612HIS A 613ASP A 764LEU A 765PHE A 820 | VDN A 1 (-4.8A)VDN A 1 (-4.3A)NoneVDN A 1 ( 4.7A)VDN A 1 (-3.6A) | 0.68A | 1xoqB-3b2rA:31.7 | 1xoqB-3b2rA:31.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3bjc | CGMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE (Homo sapiens) |
PF00233(PDEase_I) | 5 | TYR A 612HIS A 613ASP A 764LEU A 765PHE A 820 | None MG A 877 (-4.4A) ZN A 876 (-2.5A)WAN A 901 ( 4.7A)WAN A 901 (-3.7A) | 0.67A | 1xoqB-3bjcA:34.3 | 1xoqB-3bjcA:17.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3cpi | RAB GDP-DISSOCIATIONINHIBITOR (Saccharomycescerevisiae) |
PF00996(GDI) | 5 | LEU G 239TYR G 415THR G 20ILE G 23PHE G 421 | None | 1.45A | 1xoqB-3cpiG:undetectable | 1xoqB-3cpiG:21.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3e79 | HIGH AFFINITYTRANSPORT SYSTEMPROTEIN P37 (Mycoplasmahyorhinis) |
PF06646(Mycoplasma_p37) | 5 | ASP A 280LEU A 277ILE A 304SER A 307PHE A 306 | None | 1.39A | 1xoqB-3e79A:undetectable | 1xoqB-3e79A:22.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ecn | HIGH AFFINITYCAMP-SPECIFIC ANDIBMX-INSENSITIVE3',5'-CYCLICPHOSPHODIESTERASE 8A (Homo sapiens) |
PF00233(PDEase_I) | 8 | TYR A 555HIS A 556ASP A 726PRO A 730TRP A 740ILE A 744SER A 777PHE A 781 | NoneNone ZN A 1 (-2.6A)NoneNoneIBM A 3 (-4.3A)NoneIBM A 3 (-3.5A) | 0.37A | 1xoqB-3ecnA:45.0 | 1xoqB-3ecnA:33.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3fs3 | NUCLEOSOME ASSEMBLYPROTEIN 1, PUTATIVE (Plasmodiumfalciparum) |
PF00956(NAP) | 5 | ASP A 121LEU A 125ILE A 188SER A 161PHE A 152 | None | 1.26A | 1xoqB-3fs3A:undetectable | 1xoqB-3fs3A:22.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3g4g | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homo sapiens) |
PF00233(PDEase_I) | 6 | HIS A 326ASP A 484LEU A 485MET A 523SER A 534PHE A 538 | D71 A 901 (-4.5A) ZN A 801 (-2.6A)NoneD71 A 901 ( 4.0A)D71 A 901 (-3.4A)D71 A 901 (-3.9A) | 0.90A | 1xoqB-3g4gA:52.7 | 1xoqB-3g4gA:81.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3g4g | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homo sapiens) |
PF00233(PDEase_I) | 11 | TYR A 325HIS A 326ASP A 484LEU A 485PRO A 488TYR A 495TRP A 498THR A 499ILE A 502MET A 523PHE A 538 | NoneD71 A 901 (-4.5A) ZN A 801 (-2.6A)NoneNoneNoneNoneD71 A 901 (-3.6A)D71 A 901 (-4.1A)D71 A 901 ( 4.0A)D71 A 901 (-3.9A) | 0.49A | 1xoqB-3g4gA:52.7 | 1xoqB-3g4gA:81.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3gyw | NUCLEOSOME ASSEMBLYPROTEIN 1, PUTATIVE (Plasmodiumfalciparum) |
PF00956(NAP) | 5 | ASP A 121LEU A 125ILE A 188SER A 161PHE A 152 | None | 1.20A | 1xoqB-3gywA:undetectable | 1xoqB-3gywA:20.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3hoc | FILAMIN-A (Homo sapiens) |
PF00307(CH) | 5 | LEU A 172THR A 186ILE A 185SER A 189PHE A 188 | None | 1.32A | 1xoqB-3hocA:undetectable | 1xoqB-3hocA:23.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3hym | ANAPHASE-PROMOTINGCOMPLEX SUBUNITCDC26CELL DIVISION CYCLEPROTEIN 16 HOMOLOG (Homo sapiens;Homo sapiens) |
PF10471(ANAPC_CDC26)PF13424(TPR_12) | 5 | LEU A 2PRO B 335TRP B 337SER B 301PHE B 303 | None | 1.45A | 1xoqB-3hymA:undetectable | 1xoqB-3hymA:6.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ibj | CGMP-DEPENDENT3',5'-CYCLICPHOSPHODIESTERASE (Homo sapiens) |
PF00233(PDEase_I)PF01590(GAF)PF13185(GAF_2) | 6 | TYR A 655HIS A 656ASP A 808LEU A 809ILE A 826PHE A 862 | NoneNone ZN A 1 (-2.7A)NoneNoneNone | 0.98A | 1xoqB-3ibjA:32.7 | 1xoqB-3ibjA:18.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3iqd | OCTOPINEDEHYDROGENASE (Pecten maximus) |
PF02317(Octopine_DH) | 5 | PRO B 145THR B 89ILE B 87SER B 117PHE B 141 | None | 1.41A | 1xoqB-3iqdB:undetectable | 1xoqB-3iqdB:21.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3k4i | UNCHARACTERIZEDPROTEIN (Pseudomonassyringae groupgenomosp. 3) |
PF03737(RraA-like) | 5 | ASP A 174PRO A 134TYR A 133THR A 116SER A 85 | None | 1.18A | 1xoqB-3k4iA:undetectable | 1xoqB-3k4iA:20.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3k70 | EXODEOXYRIBONUCLEASEV BETA CHAIN (Escherichiacoli) |
PF00580(UvrD-helicase)PF12705(PDDEXK_1)PF13361(UvrD_C) | 5 | ASP B 798LEU B 799THR B 807MET B 499SER B 456 | None | 1.33A | 1xoqB-3k70B:undetectable | 1xoqB-3k70B:14.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3o57 | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B (Homo sapiens) |
PF00233(PDEase_I) | 12 | TYR A 233HIS A 234ASP A 392LEU A 393PRO A 396TYR A 403TRP A 406THR A 407ILE A 410MET A 431SER A 442PHE A 446 | NoneNone ZN A 1 (-2.6A)NoneZG2 A 506 ( 4.5A)NoneNoneZG2 A 506 (-4.3A)ZG2 A 506 (-4.4A)ZG2 A 506 (-3.4A)NoneZG2 A 506 (-3.6A) | 0.58A | 1xoqB-3o57A:51.8 | 1xoqB-3o57A:82.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3sl5 | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homo sapiens) |
PF00233(PDEase_I) | 11 | TYR A 159HIS A 160ASP A 318LEU A 319PRO A 322TYR A 329TRP A 332THR A 333ILE A 336MET A 357SER A 368 | TYR A 159 (-1.3A)HIS A 160 ( 1.0A)ASP A 318 (-0.5A)LEU A 319 ( 0.6A)PRO A 322 (-1.1A)TYR A 329 (-1.3A)TRP A 332 ( 0.5A)THR A 333 ( 0.8A)ILE A 336 ( 0.4A)MET A 357 (-0.0A)SER A 368 (-0.0A) | 0.49A | 1xoqB-3sl5A:53.4 | 1xoqB-3sl5A:94.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3sl5 | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homo sapiens) |
PF00233(PDEase_I) | 11 | TYR A 159HIS A 160ASP A 318LEU A 319PRO A 322TYR A 329TRP A 332THR A 333ILE A 336SER A 368PHE A 372 | TYR A 159 (-1.3A)HIS A 160 ( 1.0A)ASP A 318 (-0.5A)LEU A 319 ( 0.6A)PRO A 322 (-1.1A)TYR A 329 (-1.3A)TRP A 332 ( 0.5A)THR A 333 ( 0.8A)ILE A 336 ( 0.4A)SER A 368 (-0.0A)PHE A 372 (-1.3A) | 0.50A | 1xoqB-3sl5A:53.4 | 1xoqB-3sl5A:94.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3t3o | METAL DEPENDENTHYDROLASE (Thermusthermophilus) |
PF07521(RMMBL)PF12706(Lactamase_B_2) | 5 | HIS A 150ASP A 79ILE A 152SER A 272PHE A 271 | None ZN A 600 (-2.5A)NoneNoneNone | 1.22A | 1xoqB-3t3oA:undetectable | 1xoqB-3t3oA:23.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ui7 | CAMP ANDCAMP-INHIBITED CGMP3',5'-CYCLICPHOSPHODIESTERASE10A (Homo sapiens) |
PF00233(PDEase_I) | 6 | TYR A 524HIS A 525ASP A 674LEU A 675ILE A 692PHE A 729 | C1L A 1 ( 4.8A)C1L A 1 (-4.1A) ZN A 772 (-2.4A)C1L A 1 (-4.3A)C1L A 1 (-4.3A)C1L A 1 (-3.5A) | 0.90A | 1xoqB-3ui7A:38.5 | 1xoqB-3ui7A:28.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ui7 | CAMP ANDCAMP-INHIBITED CGMP3',5'-CYCLICPHOSPHODIESTERASE10A (Homo sapiens) |
PF00233(PDEase_I) | 5 | TYR A 524HIS A 525LEU A 635ILE A 692PHE A 729 | C1L A 1 ( 4.8A)C1L A 1 (-4.1A)NoneC1L A 1 (-4.3A)C1L A 1 (-3.5A) | 1.46A | 1xoqB-3ui7A:38.5 | 1xoqB-3ui7A:28.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3v94 | CYCLIC NUCLEOTIDESPECIFICPHOSPHODIESTERASE (Trypanosomacruzi) |
PF00233(PDEase_I) | 6 | TYR A 367HIS A 368ASP A 521TRP A 535ILE A 538PHE A 573 | WYQ A 701 (-4.5A)None ZN A 702 (-1.9A)NoneWYQ A 701 ( 4.1A)WYQ A 701 (-3.4A) | 0.71A | 1xoqB-3v94A:40.0 | 1xoqB-3v94A:30.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3vf1 | 11R-LIPOXYGENASE (Gersemiafruticosa) |
PF00305(Lipoxygenase)PF01477(PLAT) | 5 | ASP A 459LEU A 460ILE A 251SER A 240PHE A 471 | None | 1.37A | 1xoqB-3vf1A:undetectable | 1xoqB-3vf1A:19.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3vkg | DYNEIN HEAVY CHAIN,CYTOPLASMIC (Dictyosteliumdiscoideum) |
PF03028(Dynein_heavy)PF07728(AAA_5)PF08393(DHC_N2)PF12774(AAA_6)PF12775(AAA_7)PF12777(MT)PF12780(AAA_8)PF12781(AAA_9) | 5 | TYR A3601LEU A3181TYR A3233THR A3237ILE A3238 | None | 1.48A | 1xoqB-3vkgA:undetectable | 1xoqB-3vkgA:7.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3wtc | PUTATIVEOXIDOREDUCTASE (Gluconobacteroxydans) |
PF00106(adh_short) | 5 | LEU A 83THR A 179ILE A 137SER A 176PHE A 128 | None | 1.38A | 1xoqB-3wtcA:undetectable | 1xoqB-3wtcA:22.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4d2j | FRUCTOSE-BISPHOSPHATE ALDOLASE (Toxoplasmagondii) |
PF00274(Glycolytic) | 5 | LEU A 328THR A 306ILE A 320SER A 343PHE A 341 | NoneNoneNoneSO4 A1418 ( 3.9A)None | 1.47A | 1xoqB-4d2jA:undetectable | 1xoqB-4d2jA:21.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4dh2 | CELLULOSOMEANCHORING PROTEINCOHESIN REGION (Ruminiclostridiumthermocellum) |
PF00963(Cohesin) | 5 | HIS A 44ASP A 145LEU A 146ILE A 149SER A 139 | None | 1.34A | 1xoqB-4dh2A:undetectable | 1xoqB-4dh2A:18.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4htz | CGMP-DEPENDENT3',5'-CYCLICPHOSPHODIESTERASE (Homo sapiens) |
PF00233(PDEase_I) | 6 | TYR A 655HIS A 656ASP A 808LEU A 809ILE A 826PHE A 862 | NoneNone ZN A1001 (-2.5A)NoneNoneNone | 0.66A | 1xoqB-4htzA:38.8 | 1xoqB-4htzA:28.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4htz | CGMP-DEPENDENT3',5'-CYCLICPHOSPHODIESTERASE (Homo sapiens) |
PF00233(PDEase_I) | 5 | TYR A 655LEU A 809ILE A 826MET A 847PHE A 862 | None | 1.11A | 1xoqB-4htzA:38.8 | 1xoqB-4htzA:28.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4i15 | CLASS 1PHOSPHODIESTERASEPDEB1 (Trypanosomabrucei) |
PF00233(PDEase_I) | 5 | TYR A 668HIS A 669ASP A 822TRP A 836PHE A 877 | NoneNone ZN A1001 (-2.5A)NoneNone | 0.47A | 1xoqB-4i15A:38.6 | 1xoqB-4i15A:32.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ita | SUCCINATE-SEMIALDEHYDE DEHYDROGENASE (Synechococcussp. PCC 7002) |
PF00171(Aldedh) | 5 | ASP A 372LEU A 373ILE A 269SER A 390PHE A 402 | EDO A 510 (-2.9A)NoneNoneNoneNone | 1.31A | 1xoqB-4itaA:undetectable | 1xoqB-4itaA:20.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4q0w | DNA REPAIR PROTEINRAD2 (Saccharomycescerevisiae) |
PF00752(XPG_N)PF00867(XPG_I) | 5 | ASP A 815LEU A 818THR A 822ILE A 824SER A 842 | CA A1001 (-3.5A)NoneNoneNoneNone | 1.43A | 1xoqB-4q0wA:undetectable | 1xoqB-4q0wA:22.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4qp0 | ENDO-BETA-MANNANASE (Rhizomucormiehei) |
PF00150(Cellulase) | 5 | LEU A 29THR A 166ILE A 93SER A 98PHE A 41 | None | 1.49A | 1xoqB-4qp0A:undetectable | 1xoqB-4qp0A:21.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4um8 | INTEGRIN ALPHA-V (Homo sapiens) |
PF01839(FG-GAP)PF08441(Integrin_alpha2) | 5 | ASP A 24LEU A 37TYR A 11ILE A 414SER A 62 | None | 1.18A | 1xoqB-4um8A:undetectable | 1xoqB-4um8A:18.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4wzi | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B (Homo sapiens) |
PF00233(PDEase_I) | 11 | TYR A 405HIS A 406ASP A 564LEU A 565PRO A 568TRP A 578THR A 579ILE A 582MET A 603SER A 614PHE A 618 | None MG A 804 ( 4.9A) ZN A 801 (-2.5A)NoneNoneNoneNoneNoneNoneNoneNone | 0.73A | 1xoqB-4wziA:52.6 | 1xoqB-4wziA:48.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4wzi | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B (Homo sapiens) |
PF00233(PDEase_I) | 11 | TYR A 405HIS A 406ASP A 564LEU A 565PRO A 568TYR A 575TRP A 578THR A 579MET A 603SER A 614PHE A 618 | None MG A 804 ( 4.9A) ZN A 801 (-2.5A)NoneNoneNoneNoneNoneNoneNoneNone | 0.61A | 1xoqB-4wziA:52.6 | 1xoqB-4wziA:48.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4y9s | EPOXIDE HYDROLASE (Solanumtuberosum) |
PF00561(Abhydrolase_1) | 5 | HIS A 104ASP A 265LEU A 266THR A 182PHE A 189 | None | 1.42A | 1xoqB-4y9sA:undetectable | 1xoqB-4y9sA:20.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4yge | MULTIPLE COAGULATIONFACTOR DEFICIENCYPROTEIN 2 (Homo sapiens) |
PF13499(EF-hand_7) | 5 | ASP B 89LEU B 91THR B 98ILE B 97SER B 113 | CA B 502 ( 4.7A)NoneNoneNoneNone | 1.47A | 1xoqB-4ygeB:undetectable | 1xoqB-4ygeB:20.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4z0x | ANTIBODY HC26AMHEAVY CHAIN VARIABLEDOMAIN (Homo sapiens) |
PF07686(V-set) | 5 | HIS B 54LEU B 126TYR B 131THR B 60ILE B 59 | None | 1.14A | 1xoqB-4z0xB:undetectable | 1xoqB-4z0xB:16.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5b25 | CALCIUM/CALMODULIN-DEPENDENT3',5'-CYCLICNUCLEOTIDEPHOSPHODIESTERASE 1B (Homo sapiens) |
PF00233(PDEase_I) | 8 | TYR A 222HIS A 223ASP A 370PRO A 374TRP A 384THR A 385SER A 420PHE A 424 | None4QJ A 603 ( 4.9A) ZN A 601 (-2.5A)NoneNoneNone4QJ A 603 (-4.7A)4QJ A 603 (-3.5A) | 0.47A | 1xoqB-5b25A:44.0 | 1xoqB-5b25A:38.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5dc4 | AS25 MONOBODY (Homo sapiens) |
PF00041(fn3) | 5 | PRO B 27TRP B 24THR B 8ILE B 89SER B 4 | None | 1.35A | 1xoqB-5dc4B:undetectable | 1xoqB-5dc4B:15.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5dzs | SHIKIMATEDEHYDROGENASE(NADP(+)) (Clostridioidesdifficile) |
PF08501(Shikimate_dh_N) | 5 | HIS A 20LEU A 264TYR A 234ILE A 241SER A 255 | None | 1.41A | 1xoqB-5dzsA:undetectable | 1xoqB-5dzsA:22.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5g3y | ADENYLATE KINSE (syntheticconstruct) |
PF00406(ADK)PF05191(ADK_lid) | 5 | TYR A 186ASP A 97ILE A 4SER A 30PHE A 86 | NoneNoneNoneADP A1216 ( 4.8A)ADP A1216 (-4.8A) | 1.49A | 1xoqB-5g3yA:undetectable | 1xoqB-5g3yA:19.89 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5h2r | PHOSPHODIESTERASE (Trypanosomabrucei) |
no annotation | 5 | TYR A 668HIS A 669ASP A 823TRP A 837PHE A 878 | LLN A1003 ( 4.8A)None ZN A1001 (-2.6A)NoneLLN A1003 (-3.8A) | 0.33A | 1xoqB-5h2rA:39.2 | 1xoqB-5h2rA:32.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5h42 | UNCHARACTERIZEDPROTEIN (Lachnoclostridiumphytofermentans) |
PF17167(Glyco_hydro_36) | 5 | HIS A 148ASP A 189LEU A 220ILE A 127MET A 36 | None | 1.34A | 1xoqB-5h42A:undetectable | 1xoqB-5h42A:15.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5in7 | NEURONAL MIGRATIONPROTEIN DOUBLECORTIN (Homo sapiens) |
PF03607(DCX) | 5 | ASP A 167LEU A 164ILE A 149SER A 205PHE A 138 | None | 1.35A | 1xoqB-5in7A:undetectable | 1xoqB-5in7A:15.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5neu | INTEGRIN ALPHA-V (Homo sapiens) |
PF01839(FG-GAP)PF08441(Integrin_alpha2) | 5 | ASP A 24LEU A 37TYR A 11ILE A 414SER A 62 | None | 0.96A | 1xoqB-5neuA:undetectable | 1xoqB-5neuA:20.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ohj | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B (Homo sapiens) |
no annotation | 11 | TYR A 405HIS A 406ASP A 564LEU A 565PRO A 568TYR A 575TRP A 578THR A 579ILE A 582SER A 614PHE A 618 | NoneNone ZN A 699 ( 2.6A)9VE A 801 (-4.7A)9VE A 801 (-3.9A)9VE A 801 (-4.6A)None9VE A 801 (-4.1A)9VE A 801 (-4.1A)9VE A 801 (-4.7A)9VE A 801 (-3.9A) | 0.15A | 1xoqB-5ohjA:51.9 | 1xoqB-5ohjA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ohj | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B (Homo sapiens) |
no annotation | 9 | TYR A 405LEU A 565PRO A 568TYR A 575TRP A 578THR A 579ILE A 582MET A 603PHE A 618 | None9VE A 801 (-4.7A)9VE A 801 (-3.9A)9VE A 801 (-4.6A)None9VE A 801 (-4.1A)9VE A 801 (-4.1A)9VE A 801 (-3.6A)9VE A 801 (-3.9A) | 0.55A | 1xoqB-5ohjA:51.9 | 1xoqB-5ohjA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5op0 | DNA POLYMERASE LIGD,POLYMERASE DOMAIN (Mycolicibacteriumsmegmatis) |
no annotation | 5 | TYR B 74ASP B 238PRO B 123THR B 120SER B 176 | None | 1.22A | 1xoqB-5op0B:undetectable | 1xoqB-5op0B:22.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5u09 | CANNABINOID RECEPTOR1,GLGA GLYCOGENSYNTHASE (Homo sapiens;Pyrococcusabyssi) |
PF00001(7tm_1)PF00534(Glycos_transf_1) | 5 | LEU A 341TYR A 294ILE A 348SER A 206PHE A 155 | None | 1.24A | 1xoqB-5u09A:undetectable | 1xoqB-5u09A:19.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5vyd | PHOSPHODIESTERASE (Salpingoecarosetta) |
no annotation | 5 | HIS A 83ASP A 236LEU A 237PRO A 240PHE A 291 | None ZN A 401 (-2.4A)NoneNoneNone | 0.53A | 1xoqB-5vydA:40.0 | 1xoqB-5vydA:32.87 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5vyd | PHOSPHODIESTERASE (Salpingoecarosetta) |
no annotation | 5 | HIS A 83ASP A 236LEU A 237TRP A 250PHE A 291 | None ZN A 401 (-2.4A)NoneNoneNone | 0.68A | 1xoqB-5vydA:40.0 | 1xoqB-5vydA:32.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5wh6 | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homo sapiens) |
no annotation | 9 | HIS A 160LEU A 319PRO A 322TYR A 329TRP A 332THR A 333ILE A 336MET A 357SER A 368 | NoneAKJ A 601 ( 4.6A)AKJ A 601 (-3.9A)AKJ A 601 (-4.8A)NoneAKJ A 601 (-4.1A)AKJ A 601 (-3.8A)AKJ A 601 (-3.4A)AKJ A 601 (-2.5A) | 0.65A | 1xoqB-5wh6A:55.1 | 1xoqB-5wh6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5wh6 | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homo sapiens) |
no annotation | 11 | TYR A 159HIS A 160ASP A 318LEU A 319PRO A 322TYR A 329TRP A 332THR A 333ILE A 336MET A 357PHE A 372 | AKJ A 601 ( 4.7A)None ZN A 602 (-2.5A)AKJ A 601 ( 4.6A)AKJ A 601 (-3.9A)AKJ A 601 (-4.8A)NoneAKJ A 601 (-4.1A)AKJ A 601 (-3.8A)AKJ A 601 (-3.4A)AKJ A 601 (-4.1A) | 0.42A | 1xoqB-5wh6A:55.1 | 1xoqB-5wh6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5xjh | POLY(ETHYLENETEREPHTHALATE)HYDROLASE (Ideonellasakaiensis) |
no annotation | 5 | PRO A 99TYR A 69THR A 110ILE A 83SER A 92 | None | 1.08A | 1xoqB-5xjhA:undetectable | 1xoqB-5xjhA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5xjh | POLY(ETHYLENETEREPHTHALATE)HYDROLASE (Ideonellasakaiensis) |
no annotation | 5 | PRO A 99TYR A 69THR A 110ILE A 83SER A 93 | None | 1.33A | 1xoqB-5xjhA:undetectable | 1xoqB-5xjhA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6ane | POLY(ETHYLENETEREPHTHALATE)HYDROLASE (Ideonellasakaiensis) |
no annotation | 5 | PRO A 72TYR A 42THR A 83ILE A 56SER A 65 | None | 1.06A | 1xoqB-6aneA:undetectable | 1xoqB-6aneA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6ane | POLY(ETHYLENETEREPHTHALATE)HYDROLASE (Ideonellasakaiensis) |
no annotation | 5 | PRO A 72TYR A 42THR A 83ILE A 56SER A 66 | None | 1.33A | 1xoqB-6aneA:undetectable | 1xoqB-6aneA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6f8z | ALPHA-1,2-MANNOSIDASE, PUTATIVE (Bacteroidesthetaiotaomicron) |
no annotation | 5 | ASP A 98LEU A 96TYR A 45THR A 49ILE A 55 | None | 1.37A | 1xoqB-6f8zA:undetectable | 1xoqB-6f8zA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6fn1 | HUMAN-MOUSE CHIMERICABCB1 (ABCBHM) (Homo sapiens) |
no annotation | 5 | LEU A 832TYR A 997THR A1001SER A 695PHE A 696 | None | 1.12A | 1xoqB-6fn1A:undetectable | 1xoqB-6fn1A:undetectable |